- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Type 2 Diabetes Mellitus (T2DM)
- Meeting Date: July 2020
- Public Summary Document (PSD) July 2020 PBAC Meeting - (PDF 949KB)
- Public Summary Document (PSD) July 2020 PBAC Meeting - (Word 72KB)
Dulaglutide – July 2020
Dulaglutide: Injection 1.5 mg in 0.5 mL single dose pre-filled pen; Trulicity®
Last updated
30 October 2020